The potential effects of newer groups of glucose lowering drugs on age-related macular degeneration
Eye (Lond)
.
2024 Sep;38(13):2649-2650.
doi: 10.1038/s41433-024-03066-5.
Epub 2024 Apr 11.
Authors
Moein Ebrahimi
1
2
,
Sobha Sivaprasad
3
Affiliations
1
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2
Network of Immunity in Infection, Malignancy, and Autoimmunity, Universal Scientific Education and Research Network (USERN), Tehran, Iran.
3
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
[email protected]
.
PMID:
38605074
PMCID:
PMC11383937
(available on
2025-09-01
)
DOI:
10.1038/s41433-024-03066-5
No abstract available
Publication types
Letter
MeSH terms
Humans
Hypoglycemic Agents* / adverse effects
Hypoglycemic Agents* / therapeutic use
Macular Degeneration* / drug therapy
Substances
Hypoglycemic Agents